One of the major concerns in the COVID-19 pandemic is related to the possible transmission in poorly ventilated spaces of SARS-CoV-2 through aerosol microdroplets, which can remain in the air for long periods of time and be transmitted to others over distances '1 m. Cold atmospheric pressure plasmas can represent a promising solution, thanks to their ability in producing a blend of many reactive species, which can inactivate the airborne aerosolized microorganisms. In this study, a dielectric barrier discharge plasma source is used to directly inactivate suitably produced bioaerosols containing Staphylococcus epidermidis or purified SARS-CoV-2 RNA flowing through it. Results show that for low residence times ('0.2 s) in the plasma region a 3.7 log R on bacterial bioaerosol and degradation of viral RNA can be achieved.

Cold atmospheric plasma inactivation of aerosolized microdroplets containing bacteria and purified SARS-CoV-2 RNA to contrast airborne indoor transmission / Bisag A.; Isabelli P.; Laurita R.; Bucci C.; Capelli F.; Dirani G.; Gherardi M.; Laghi G.; Paglianti A.; Sambri V.; Colombo V.. - In: PLASMA PROCESSES AND POLYMERS. - ISSN 1612-8850. - STAMPA. - 17:10 SI(2020), pp. 2000154.1-2000154.8. [10.1002/ppap.202000154]

Cold atmospheric plasma inactivation of aerosolized microdroplets containing bacteria and purified SARS-CoV-2 RNA to contrast airborne indoor transmission

Bisag A.;Isabelli P.;Laurita R.
;
Dirani G.;Gherardi M.;Laghi G.;Paglianti A.;Sambri V.;Colombo V.
2020

Abstract

One of the major concerns in the COVID-19 pandemic is related to the possible transmission in poorly ventilated spaces of SARS-CoV-2 through aerosol microdroplets, which can remain in the air for long periods of time and be transmitted to others over distances '1 m. Cold atmospheric pressure plasmas can represent a promising solution, thanks to their ability in producing a blend of many reactive species, which can inactivate the airborne aerosolized microorganisms. In this study, a dielectric barrier discharge plasma source is used to directly inactivate suitably produced bioaerosols containing Staphylococcus epidermidis or purified SARS-CoV-2 RNA flowing through it. Results show that for low residence times ('0.2 s) in the plasma region a 3.7 log R on bacterial bioaerosol and degradation of viral RNA can be achieved.
2020
Cold atmospheric plasma inactivation of aerosolized microdroplets containing bacteria and purified SARS-CoV-2 RNA to contrast airborne indoor transmission / Bisag A.; Isabelli P.; Laurita R.; Bucci C.; Capelli F.; Dirani G.; Gherardi M.; Laghi G.; Paglianti A.; Sambri V.; Colombo V.. - In: PLASMA PROCESSES AND POLYMERS. - ISSN 1612-8850. - STAMPA. - 17:10 SI(2020), pp. 2000154.1-2000154.8. [10.1002/ppap.202000154]
Bisag A.; Isabelli P.; Laurita R.; Bucci C.; Capelli F.; Dirani G.; Gherardi M.; Laghi G.; Paglianti A.; Sambri V.; Colombo V.
File in questo prodotto:
File Dimensione Formato  
ppap.202000154.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.17 MB
Formato Adobe PDF
1.17 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/809307
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 69
  • ???jsp.display-item.citation.isi??? 60
social impact